Life After the FDA Social Media Hearings: Applying the rules today

Share this article:

Click here to view on demand

With the FDA Internet and social media hearings now complete, many Pharma marketers are left trying to answer the question, "what am I supposed to do TODAY?" Formal guidance may not be issued until 2011, yet marketers still have the need to execute digital programs responsibly.

Experts from pharma marketing, digital media and regulatory disciplines will use case studies to examine the key regulatory challenges surrounding online marketing and offer potential solutions and tactics for effectively leveraging this channel within the complex legal environment.

The event will focus on the following core online strategies:

  • Websites
  • Search Marketing
  • Display Advertising
  • Social Media

Moderator
Marc Iskowitz, executive editor, Medical Marketing & Media

Sponsored by Klick Pharma


Share this article:

Email Newsletters

More in Webcasts

Delighting Your Customer through Multichannel Customer Engagement

Today's life sciences customers expect service delivered on their terms. They want the convenience of email, phone, web, and face-to-face - all personalized, all coordinated. The typical experience they receive as a consumer.

The New World of the Customer Experience - Not Your Daddy's Call ...

In this webcast, we will talk about how TrialCard's Customer Experience Center has become the focal point of our business - from inbound support for pharmacies, physicians, and patients through teledetailing and whitespace management to insurance verification and marketing research.

Green light, or go slow: What FDA's new draft guidance means ...

While not the last word on the subject, the agency's latest social media guidance was a good step forward. This informative webcast is designed to dissect the guidance and help brand directors and communication managers, whether currently engaging in social media or looking to do ...